OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001632053

Apotheca Biosciences, Inc.

Apotheca Biosciences, Inc. (CIK 0001632053, EIN 47-2055848) reported net income of -$195,780 for FY2018 (2017-02-01 to 2018-01-31) and total assets of $115,325 for FY2019 (as of 2019-01-31), as filed in its 10-K filed 2018-05-18 (accession 0001562884-18-000064) and its 10-K filed 2019-05-16 (accession 0001079974-19-000277).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends January 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001632053
EIN47-2055848
SIC industry code1000 Metal Mining
State or country of incorporationNV
Fiscal year endJanuary 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_1e72rfc1sebq53fvmj60kjvsq3
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Net income-$195,780FY20182017-02-01 to 2018-01-3110-K2018-05-180001562884-18-000064NetIncomeLoss
Total assets$115,325FY2019as of 2019-01-3110-K2019-05-160001079974-19-000277Assets
Total liabilities$931,878FY2019as of 2019-01-3110-K2019-05-160001079974-19-000277Liabilities
Stockholders' equity-$816,553FY2019as of 2019-01-3110-K2019-05-160001079974-19-000277StockholdersEquity
Operating cash flow-$34,089FY20182017-02-01 to 2018-01-3110-K2018-05-180001562884-18-000064NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share$0 per shareFY20182017-02-01 to 2018-01-3110-K2018-05-180001562884-18-000064EarningsPerShareBasicAndDiluted
Shares outstanding118,664,000 sharesFY2019as of 2019-05-1510-K2019-05-160001079974-19-000277EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2010-2019, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
Net incomeFY20182017-02-01 to 2018-01-31-$195,78010-K2018-05-180001562884-18-000064
Net incomeFY20172016-02-01 to 2017-01-31-$17,78610-K2018-05-180001562884-18-000064
Net incomeFY20162015-02-01 to 2016-01-31-$39,38810-K2017-05-160001594062-17-000120

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q/A2019-06-202019-04-300001079974-19-000337apthotheca10qa1_4302019.htm
10-Q2019-06-192019-04-300001079974-19-000328apthotheca10q_4302019.htm
10-K2019-05-162019-01-310001079974-19-000277apotheca10k_1312019.htm
10-Q2018-12-192018-10-310001079974-18-000674apotheca10q_10312018.htm
10-Q2018-10-022018-07-310001079974-18-000540apothica10q_7312018.htm
10-Q2018-06-202018-04-300001562884-18-000072pcpf-20180430_10q.htm
10-K2018-05-182018-01-310001562884-18-000064pcpf-20180131_10k.htm
10-Q2018-02-092017-10-310001562884-18-000006pcpf-20171031_10q.htm
10-Q/A2018-02-092017-07-310001562884-18-000004pcpf-20170731_10qa.htm
10-Q/A2017-09-202017-07-310001594062-17-000226form10qa.htm
10-Q2017-09-192017-07-310001594062-17-000224form10q.htm
10-Q2017-06-212017-04-300001594062-17-000158form10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001632053published by the sourcedata.sec.gov/submissions/CIK0001632053.json2026-10-21
Employer Identification Number (EIN) · US-EIN47-2055848published by the sourcedata.sec.gov/submissions/CIK0001632053.json2026-10-21

Former names

NameFromTo
Cannabis Leaf, Inc.2017-07-312018-08-06
Pacificorp Holdings Ltd.2015-04-212017-06-22

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001632053.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001632053.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001632053" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001632053/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001632053/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1632053"}

On SEC EDGAR

About this data